- Home
- TNGX vs GOOD Comparison
TNGX vs GOOD Comparison
Compare TNGX & GOOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- GOOD
- Stock Information
- Founded
- TNGX 2014
- GOOD 2003
- Country
- TNGX United States
- GOOD United States
- Employees
- TNGX N/A
- GOOD N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- GOOD Real Estate Investment Trusts
- Sector
- TNGX Health Care
- GOOD Real Estate
- Exchange
- TNGX Nasdaq
- GOOD Nasdaq
- Market Cap
- TNGX 723.0M
- GOOD 670.2M
- IPO Year
- TNGX N/A
- GOOD N/A
- Fundamental
- Price
- TNGX $6.53
- GOOD $13.01
- Analyst Decision
- TNGX Strong Buy
- GOOD Hold
- Analyst Count
- TNGX 5
- GOOD 1
- Target Price
- TNGX $10.50
- GOOD $15.00
- AVG Volume (30 Days)
- TNGX 1.9M
- GOOD 408.8K
- Earning Date
- TNGX 08-05-2025
- GOOD 08-06-2025
- Dividend Yield
- TNGX N/A
- GOOD 9.23%
- EPS Growth
- TNGX N/A
- GOOD N/A
- EPS
- TNGX N/A
- GOOD 0.30
- Revenue
- TNGX $40,990,000.00
- GOOD $151,168,000.00
- Revenue This Year
- TNGX N/A
- GOOD $4.73
- Revenue Next Year
- TNGX N/A
- GOOD $2.84
- P/E Ratio
- TNGX N/A
- GOOD $44.08
- Revenue Growth
- TNGX 10.09
- GOOD 3.01
- 52 Week Low
- TNGX $1.03
- GOOD $12.67
- 52 Week High
- TNGX $12.02
- GOOD $17.88
- Technical
- Relative Strength Index (RSI)
- TNGX 60.33
- GOOD 29.82
- Support Level
- TNGX $6.36
- GOOD $13.31
- Resistance Level
- TNGX $7.11
- GOOD $13.69
- Average True Range (ATR)
- TNGX 0.52
- GOOD 0.26
- MACD
- TNGX -0.13
- GOOD -0.07
- Stochastic Oscillator
- TNGX 53.15
- GOOD 7.95
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About GOOD Gladstone Commercial Corporation Real Estate Investment Trust
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.